|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM29047745X |
| 003 |
DE-627 |
| 005 |
20250224084918.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2019 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2018.11.001
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n0968.xml
|
| 035 |
|
|
|a (DE-627)NLM29047745X
|
| 035 |
|
|
|a (NLM)30415085
|
| 035 |
|
|
|a (PII)S1521-6616(18)30442-X
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Comte, Denis
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Signaling lymphocyte activation molecule family in systemic lupus erythematosus
|
| 264 |
|
1 |
|c 2019
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 30.03.2020
|
| 500 |
|
|
|a Date Revised 03.02.2021
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2018 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease characterized by a breakdown in immune tolerance leading to the development of auto-reactive lymphocytes and autoantibodies. Recent findings have provided new insight on the role of the signaling lymphocytic activation molecule family (SLAMF) receptors, a group of nine co-regulatory molecules involved in the activation of hematopoietic cells, and their downstream protein SLAM-associated protein (SAP), into the pathogenesis of SLE. This review summarizes the current knowledge on SLAMF in human SLE immunopathogenesis, and the importance of SLAMF molecules as new therapeutic targets
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
7 |
|a Signaling Lymphocytic Activation Molecule Family
|2 NLM
|
| 700 |
1 |
|
|a Karampetsou, Maria P
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Humbel, Morgane
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tsokos, George C
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 204(2019) vom: 01. Juli, Seite 57-63
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:204
|g year:2019
|g day:01
|g month:07
|g pages:57-63
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2018.11.001
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 204
|j 2019
|b 01
|c 07
|h 57-63
|